Small RNA binding exonuclease protection factor La like 6, pseudogene (SSBL6P)

Small RNA binding exonuclease protection factor La like 6, pseudogene (SSBL6P) is classified as a pseudogene. Pseudogenes are genomic regions that closely resemble protein-coding genes in sequence, but have lost their ability to encode functional proteins due to mutations, deletions, or lack of regulatory elements[1][3][4][6]. SSBL6P is annotated as such and does not have an associated protein product or established function in RNA metabolism, disease, or therapeutics. There is no evidence in available gene/protein databases or scientific literature that this pseudogene serves as a direct therapeutic target, biomarker, or part of any recognized molecular pathway, nor does it interact with known drugs[1][3]. Pseudogenes in general may play a role in gene regulation (e.g., by acting as competing endogenous RNAs or influencing the regulation of related genes), but specific biological or clinical roles for SSBL6P have not been described in the literature[2][4][6]. No functional protein product, molecular activity, or disease association has been attributed to SSBL6P as of the current scientific consensus. Summary of the assessment: - SSBL6P is not a therapeutic target, enzyme, receptor, or druggable molecule. - The name is correct, but this is not a target in the pharmacological sense (hence: is_incorrect: true). - It is categorized molecularly as a pseudogene. - No functional, pathological, or therapeutic data are available for this pseudogene specifically. References for all above statements derive from gene annotation databases and scientific reviews on pseudogenes[1][3][4][6].

Other names

SSBL6Psmall RNA binding exonuclease protection factor La like 6pseudogene